optimizing the use of daratumumab in al amyloidosis
Published 2 years ago • 574 plays • Length 2:41Download video MP4
Download video MP3
Similar videos
-
2:36
andromeda: daratumumab cybord for al amyloidosis
-
5:07
daratumumab in the management of al amyloidosis
-
1:53
altitude: venetoclax, daratumumab, and dexamethasone in systemic al amyloidosis with t(11;14)
-
2:43
impact of the addition of daratumumab to the frontline treatment of patients with al amyloidosis
-
1:55
factors predicting outcomes in patients with al amyloidosis treated with daratumumab
-
1:36
results from vital: survival benefit of birtamimab in mayo stage iv al amyloidosis
-
4:30
andromeda: daratumumab for al amyloidosis
-
3:10
what is al amyloidosis?
-
1:40:47
latest advances in type 1 diabetes research with dr. douglas melton | jdrf lecture & q&a | sep. 2022
-
6:47
al amyloidosis and a critical, early diagnosis
-
1:49
key challenges that remain in the diagnosis of al amyloidosis
-
2:46
single use daratumumab for al amyloidosis
-
1:03
real-world management of patients with al amyloidosis
-
1:48
a phase ii study of daratumumab and pomalidomide in previously treated patients with al amyloidosis
-
3:01
novel promising agents and clinical trials in amyloidosis
-
0:55
the safety and efficacy of elranatamab in patients with r/r al amyloidosis
-
2:55
chemotherapy-free approaches to al amyloidosis
-
1:06
daratumumab and carfilzomib for al amyloid neuropathy
-
2:47
magnestismm-1: elranatamab alone or with immunomodulatory agents in r/r multiple myeloma
-
1:35
vital results for birtamimab in al amyloidosis
-
1:10
exploring the next era of treating al amyloidosis: role of birtamimab
-
0:47
unmet needs in amyloidosis treatment in the uk